Truedsson L, Awdeh Z, Yunis E J, Mrose S, Moore B, Alper C A
Center for Blood Research, Boston, MA 02115.
Immunogenetics. 1989;30(6):414-21. doi: 10.1007/BF02421172.
C4 protein variants were analyzed in 64 individuals, of which 51 were either homozygous or heterozygous for an extended major histocompatibility complex (MHC) haplotype (a fixed combination of MHC alleles). The relative amount of each C4 variant was measured by densitometric scanning of stained immunofixed electrophoretic patterns of neuraminidase- and carboxypeptidase-treated samples. The relative concentrations of C4 variants on any haplotype were stable and inherited in families. In five of the eight extended haplotypes investigated, the amount of one of the C4 variants relative to others in the same pattern was increased: [HLA-B8, SC01, DR3] and [HLA-B7, SC31, DR2] produced an approximately doubled amount of C4B1; [HLA-B18, S042, DR2] an increased amount of C4B2; and [HLA-B44, SC30, DR4] a double amount of C4A3. The extended haplotype [HLA-Bw57, SC61, DR7] gave rise to two to three times as much C4B1 as C4A6. In the extended haplotypes [HLA-B44, FC31, DR7] and [HLA-Bw62, SC33, DR4], the results did not clearly indicate differences in expression of the C4 isotypes. DNA analysis possibly supported an actual gene duplication only for the haplotype [HLA-B7, SC31, DR2]. The results suggest that, in addition to variation in the number of structural genes, other MHC-linked mechanisms may be involved in the regulation of the relative amounts of C4A or C4B protein specified by any haplotype.
对64名个体的C4蛋白变体进行了分析,其中51人对于扩展的主要组织相容性复合体(MHC)单倍型(MHC等位基因的固定组合)为纯合子或杂合子。通过对经神经氨酸酶和羧肽酶处理的样本的染色免疫固定电泳图谱进行光密度扫描,测量每种C4变体的相对含量。任何单倍型上C4变体的相对浓度是稳定的且可在家族中遗传。在研究的8种扩展单倍型中的5种中,同一样式中一种C4变体相对于其他变体的量增加:[HLA - B8,SC01,DR3]和[HLA - B7,SC31,DR2]产生的C4B1量增加了约一倍;[HLA - B18,S042,DR2]产生的C4B2量增加;[HLA - B44,SC30,DR4]产生的C4A3量翻倍。扩展单倍型[HLA - Bw57,SC61,DR7]产生的C4B1量是C4A6的两到三倍。在扩展单倍型[HLA - B44,FC31,DR7]和[HLA - Bw62,SC33,DR4]中,结果未明确表明C4同种型表达存在差异。DNA分析可能仅支持单倍型[HLA - B7,SC31,DR2]实际存在基因重复。结果表明,除了结构基因数量的变化外,其他与MHC相关的机制可能参与调节任何单倍型所指定的C4A或C4B蛋白的相对量。